Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 May;13(5):711–716. doi: 10.1111/j.1365-2125.1982.tb01441.x

An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.

D W Pitcher, P V Curry, J R Trounce
PMCID: PMC1402092  PMID: 6123343

Abstract

1 Prizidilol hydrochloride (SK&F 92657) is a new compound which causes both arteriolar dilatation and beta-adrenoceptor blockade. The effect of a single oral dose on the responses of heart rate and blood pressure to isoprenaline infusion has been studied in healthy volunteers. 2 Isoprenaline heart rate dose-response curves showed parallel shifts to the right after oral prizidilol, indicating antagonism by this compound at beta-adrenoceptors in the heart. 3 Isoprenaline dose-response curves for decreases in diastolic blood pressure also showed shifts to the right after oral prizidilol, providing evidence of beta-adrenoceptor antagonism by this drug in peripheral resistance vessels. 4 The peak effect of a 40 mg dose of propranolol was greater than that of a 200 mg dose of prizidilol but both drugs caused persistent beta-adrenoceptor blockade for at least 7 h after ingestion.

Full text

PDF
711

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collier J. G., Pitcher D. W. Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man. Br J Clin Pharmacol. 1980 Dec;10(6):567–571. doi: 10.1111/j.1365-2125.1980.tb00512.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. McDevitt D. G. The assessment of beta-adrenoceptor blocking drugs in man. Br J Clin Pharmacol. 1977 Aug;4(4):413–425. doi: 10.1111/j.1365-2125.1977.tb00756.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Steiner J. A., Clancy A., Manghani K. K., James I. M. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers. Br J Clin Pharmacol. 1981 Oct;12(4):573–578. doi: 10.1111/j.1365-2125.1981.tb01267.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Taylor E. M., Roe A. M., Slater R. A. SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade. Clin Sci (Lond) 1979 Dec;57 (Suppl 5):433s–436s. doi: 10.1042/cs057433s. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES